The chemical substance known as 4′-[(1S)-1-Fluoro-1-methyl-2-[[(1-methylethyl)sulfonyl]amino]ethyl]-N-methyl[1,1′-biphenyl]-4-carboxamide, with the CAS number 625820-83-9, is a synthetic organic compound characterized by its complex structure, which includes a biphenyl moiety, a carboxamide functional group, and a sulfonamide linkage. This compound features a chiral center, indicated by the (1S) configuration, which contributes to its potential biological activity and specificity. The presence of a fluorine atom and a methyl group enhances its lipophilicity, potentially influencing its pharmacokinetic properties. The sulfonamide group is known for its role in medicinal chemistry, often contributing to the compound's biological efficacy. Overall, this compound may exhibit interesting pharmacological properties, making it a candidate for further research in drug development, particularly in areas related to its target biological pathways. Its detailed characterization would typically involve techniques such as NMR spectroscopy, mass spectrometry, and X-ray crystallography to elucidate its structure and confirm its purity.

4′-[(1S)-1-Fluoro-1-methyl-2-[[(1-methylethyl)sulfonyl]amino]ethyl]-N-methyl[1,1′-biphenyl]-4-carboxamide

625820-83-9: The chemical substance known as 4′-[(1S)-1-Fluoro-1-methyl-2-[[(1-methylethyl)sulfonyl]amino]ethyl]-N-methyl[1,1′-biphenyl]-4-carboxamide, with the CAS number 625820-83-9, is a synthetic organic compound characterized by its complex structure, which includes a biphenyl moiety, a carboxamide functional group, and a sulfonamide linkage. This compound features a chiral center, indicated by the (1S) configuration, which contributes to its potential biological activity and specificity. The presence of a fluorine atom and a methyl group enhances its lipophilicity, potentially influencing its pharmacokinetic properties. The sulfonamide group is known for its role in medicinal chemistry, often contributing to the compound's biological efficacy. Overall, this compound may exhibit interesting pharmacological properties, making it a candidate for further research in drug development, particularly in areas related to its target biological pathways. Its detailed characterization would typically involve techniques such as NMR spectroscopy, mass spectrometry, and X-ray crystallography to elucidate its structure and confirm its purity.

<p>LY503430: Oral AMPA enhancer with nootropic, neuroprotective properties, mitigates 6-OHDA/MPTP brain damage.</p>

CAS 625820-83-9

4′-[(1S)-1-Fluoro-1-methyl-2-[[(1-methylethyl)sulfonyl]amino]ethyl]-N-methyl[1,1′-biphenyl]-4-carboxamide

LY503430

Ref: TM-T27959